Top Markets
#1 Akedo Akedo +61.77%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +50.05%
#4 Velvet Velvet +41.65%
#5 Black Phoenix Black Phoenix +34.60%
#6 Ο„emplar Ο„emplar +27.06%
#7 Not in Employment, Education, or Training Not in Employment, Education, or Training +18.57%
#8 Bitway Bitway +17.22%
#9 Perle Perle +16.80%
#10 Cap Cap +16.64%
Coin of the day
Akedo Akedo
Settings
Language
ENGLISH
Currency
USD
Theme
Visioneering Technologies, Inc. Visioneering Technologies, Inc.

Visioneering Technologies, Inc.

VTI
Rank in Stocks #38209
Visioneering Technologies, Inc. is a medical device company focused on the... Visioneering Technologies, Inc. is a medical device company focused on the development, production, marketing, and distribution of contact lenses. Its commercial activities extend across North America, Europe, and the Asia-Pacific regions. The company's primary offering is NaturalVue, a multifocal contact lens engineered to help adults experiencing presbyopia and children with myopia. Visioneering Technologies was established in 2008 and has its main office situated in Alpharetta, Georgia.
Share Price
$0.04200239
Last synced: 2025-02-17
Market Cap
$1.13M
Change (1 day)
0.21%
Change (1 year)
0.00%
Country
US
Trade Visioneering Technologies, Inc. (VTI)

Category

Healthcare
P/E ratio for Visioneering Technologies, Inc. (VTI)
P/E ratio as of August 2026 TTM: -0.31
According to Visioneering Technologies, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -0.31. At the end of 2022 the company had a P/E ratio of -1.24.
P/E ratio history for Visioneering Technologies, Inc. from 2016 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) -0.31 -82.03%
2023 -1.72 39.13%
2022 -1.24 -84.70%
2021 -8.09 282.25%
2020 -2.12 51.94%
2019 -1.39 -23.49%
2018 -1.82 -63.96%
2017 -5.05 -99.27%
2016 -688.94 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 33.99 -11,095.50%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 33.47 -10,929.44%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 21.39 -7,019.38%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 18.84 -6,195.99%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 49.47 -16,103.07%
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.